Showing results (1471-1480 of 5,837) with videos related to

Sort By:
Pageof 584
Drug Design, Development and Therapy|June 17, 2016
Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal modelAbubakar Amali Muhammad, Palanisamy Arulselvan, Pike See Cheah, et al.
Drug Design, Development and Therapy|June 17, 2016
Sulfasalazine inhibits inflammation and fibrogenesis in pancreas via NF-κB signaling pathway in rats with oxidative stress-induced pancreatic injuryYa-Ru Wang, Fei-Long Tian, Ming-Xian Yan, et al.
Drug Design, Development and Therapy|June 17, 2016
An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naïve to enzyme replacement therapyOzlem Goker-Alpan, Nicola Longo, Marie McDonald, et al.
Drug Design, Development and Therapy|June 18, 2016
Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγLiang Ma, Taijin Wang, Min Shi, et al.
Drug Design, Development and Therapy|June 9, 2016
Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injuryYanzhe Wang, Zhiyi He, Shumin Deng
Drug Design, Development and Therapy|June 9, 2016
Electroporation-delivered transdermal neostigmine in rats: equivalent action to intravenous administrationSzilvia Berkó, Kálmán F Szűcs, Boglárka Balázs, et al.
Drug Design, Development and Therapy|May 25, 2016
Design, synthesis, and biological evaluation of 3-vinyl-quinoxalin-2(1H)-one derivatives as novel antitumor inhibitors of FGFR1Zhiguo Liu, Shufang Yu, Di Chen, et al.
Drug Design, Development and Therapy|May 25, 2016
Simultaneous targeting of MyD88 and Nur77 as an effective approach for the treatment of inflammatory diseasesSaqib Uzma, Mirza S Baig
Drug Design, Development and Therapy|May 25, 2016
Spirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in ratsHao Zhou, Dan Xi, Jichen Liu, et al.
Drug Design, Development and Therapy|August 1, 2015
Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimensChen Yang, Ying Liu, Wen-qi Xi, et al.
Pageof 584